MAP1B risk_factor_for Alzheimer’s disease
Evidence from:
primary |
all sources
Evidence (2 sources)
Integrative transcriptome analyses of the aging brain implicate altered splicing in Alzheimer's disease susceptibility.
(2018)
PMID:30297968
cited
newly validated Alzheimer’s disease genes ... MAP1B
confidence: 0.90
Integrative transcriptome analyses of the aging brain implicate altered splicing in Alzheimer's disease susceptibility.
(2018)
PMID:30297968
cited
found several new loci: ... MAP1B ... reinforce the association of the ... with Alzheimer’s disease susceptibility
confidence: 0.94